| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.03 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |